Comprehension of Top 200 Prescribed Drugs in the US As a Resource for Pharmacy Teaching, Training and Practice
Overview
Affiliations
Pharmacists have access to a plethora of information related to drugs. Online compendia concerning top 200 prescribed drugs are readily-accessible, comparatively-easy to search. While these resources provide some information about the commonly prescribed drugs, they lack in furnishing in-depth knowledge to pharmacy students, pharmacists and other healthcare professionals. The aim of this paper is to present the relevant details of top 200 most prescribed drugs in the United States. The names and therapeutic classes of top 200 prescribed drugs were compiled from online resources. The pharmacological actions of drugs, any reported adverse reactions and black box warnings are collected from drug bank resources, such as AccessPharmacy and Lexicomp. The paper provides comprehensive information about top 200 prescribed drugs, which includes generic names, pharmacological action, route of administration and adverse reaction profile including black box warning when applicable. Overall, the drug list may serve as an easy access of ideas for pharmacists, researchers and other healthcare professionals interested in developing new strategies for treating patients with various ailments.
Huntsman D, Bulaj G Int J Environ Res Public Health. 2025; 22(2).
PMID: 40003451 PMC: 11855921. DOI: 10.3390/ijerph22020225.
Prevalence of Patient Knowledge Gaps Regarding the Purpose of Their Cardiometabolic Medications.
Chaitoff A, Zheutlin A, Linares M, Kullgren J J Gen Intern Med. 2025; .
PMID: 39930157 DOI: 10.1007/s11606-025-09407-8.
Finding a constrained number of predictor phenotypes for multiple outcome prediction.
Reps J, Wong J, Fridgeirsson E, Kim C, John L, Williams R BMJ Health Care Inform. 2025; 32(1.
PMID: 39824520 PMC: 11751890. DOI: 10.1136/bmjhci-2024-101227.
Physician-reported barriers and facilitators to thyroid hormone deprescribing in older adults.
Moretti B, Livecchi R, Taylor S, Pitt S, Gay B, Haymart M J Am Geriatr Soc. 2024; 73(2):566-573.
PMID: 39392046 PMC: 11828684. DOI: 10.1111/jgs.19219.
The Impact of the Angiotensin-Converting Enzyme Inhibitor Lisinopril on Metabolic Rate in .
Vecchie D, Wolter J, Perry J, Jumbo-Lucioni P, De Luca M Int J Mol Sci. 2024; 25(18).
PMID: 39337588 PMC: 11432024. DOI: 10.3390/ijms251810103.